Equities
  • Price (CHF)79.68
  • Today's Change0.38 / 0.48%
  • Shares traded69.68k
  • 1 Year change+18.89%
  • Beta1.0238
Data delayed at least 15 minutes, as of Nov 05 2024 12:18 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.

  • Revenue in CHF (TTM)8.33bn
  • Net income in CHF952.13m
  • Incorporated2018
  • Employees25.32k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Smith & Nephew plc4.88bn263.58m9.41bn18.00k35.642.0911.291.930.26950.26954.994.590.55350.71284.30235,984.302.994.103.624.9969.0471.275.418.021.115.480.412579.596.402.5017.94-16.884.241.85
BioMerieux SA3.58bn386.61m11.45bn14.65k29.723.1417.273.203.463.4632.0432.800.73561.825.63259,811.607.719.309.5712.3155.7256.5110.4812.381.20236.140.125817.762.398.70-20.956.878.3619.42
Sartorius AG3.12bn78.21m15.08bn13.76k154.744.8630.824.831.221.2248.6638.730.33651.849.34227,432.601.378.211.7311.8343.9550.934.0614.151.132.410.54519.59-18.6616.74-69.747.7419.143.66
Sartorius Stedim Biotech SA2.58bn159.04m17.42bn10.38k106.304.7740.586.751.791.7929.2239.950.41451.758.84257,644.002.6111.873.0415.1241.8250.966.3117.441.032.950.426618.73-20.5318.02-64.658.2821.823.90
Straumann Holding AG2.47bn307.19m18.78bn11.15k61.139.5442.037.611.931.7015.4712.340.7151.764.21222,176.908.9510.6811.8413.6372.7674.9512.5215.151.5513.150.18737.503.9212.08-43.40-2.0411.5410.12
Sonova Holding AG3.63bn601.00m19.03bn18.15k31.777.7022.245.2510.0510.0560.6641.440.63942.356.82199,818.2010.7510.8713.4513.8872.2871.9716.8017.771.0731.440.426835.21-2.985.59-5.845.771.758.20
Koninklijke Philips NV16.96bn-440.85m22.11bn69.28k----33.411.30-0.4847-0.33519.14--------258,972.70--0.3678--0.501342.1843.84-2.590.6049--5.35----1.920.052971.87---5.24--
Coloplast A/S3.32bn626.06m23.53bn16.02k40.1912.0930.127.1022.1022.10117.8673.490.62882.365.911,676,204.0011.8720.4516.1929.6967.5267.9118.8821.730.558710.600.597591.088.518.291.644.4613.155.59
Alcon AG8.33bn952.13m39.36bn25.32k41.102.1519.624.731.921.9216.7636.590.3271.875.32328,876.303.740.35384.070.386555.3852.7111.441.221.566.680.195581.128.475.74190.75--3.68--
Siemens Healthineers AG20.76bn1.75bn50.82bn71.80k28.862.9317.342.451.661.6619.6916.340.47953.023.86311,126.804.074.885.626.6037.8237.828.509.220.847719.950.479854.89-0.156610.05-25.963.599.6018.98
EssilorLuxottica SA24.28bn2.16bn96.12bn193.69k36.602.6118.883.966.116.1156.7285.660.42453.308.12134,758.403.982.734.883.2162.3461.289.387.520.622430.610.231375.453.6818.586.3716.1516.6114.13
Data as of Nov 05 2024. Currency figures normalised to Alcon AG's reporting currency: Swiss Franc CHF
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.